i think that the key to successful cancer treatment is to adequately deﬁne the objectives. Dr ALAin HenDLiSz, Head of the Gastrointestinal Cancer Clinic
research The extensive clinical research conducted by the Gastrointestinal Cancer Clinic ensures that patients have early access to new drugs and beneﬁt rapidly from the latest scien- tiﬁc advances.
One example is the SIRT trial, which assesses the beneﬁt of intra-hepatic injection of radiation-loaded microspheres in colorectal cancer that has metastasised to the liver and is unresponsive to any known drugs. This new technique requires complex interactions of several medical teams (nuclear medicine, interventional radiologists, GI oncologists and GI surgeons). It provides beneﬁt and hope to patients whose medical condition would previously have been considered impossible to treat.
Among other examples of cutting-edge research projects, the Early PET study aims to identify better, more accurate and faster ways to determine whether a tumour will respond to treatment with chemotherapy. The study combines expertise from medical oncology, radiology and metabolic imaging. Ultimately such research will make it pos- sible to quickly identify treatments that are truly effective.
93 patients with colorectal cancer treated in 2010
72 persons per 100,000 diagnosed with colorectal cancer in Belgium per year
75% of colorectal cancers are cured